-
FDA debates expansion of switch paradigm
Get set for another decade of explosive growth throughout the over-the-counter category with the familiar switch as a catalyst.
The Food and Drug Administration public meeting that took place last month addressed a proposal to expand the switch paradigm by utilizing the latest in communications and diagnostics technology and/or incorporating the most accessible healthcare professional — the retail pharmacist — into the self-care decision protocol.